Showing results (191-200 of 279) with videos related to

Sort By:
Pageof 28
Hematological Oncology|July 8, 2020
Kinetics of pre-myelodysplastic syndromes blood values correlate with disease risk and survivalErel Joffe, Uri Greenbaum, Gili Man-El, et al.
Annals of Hematology|July 25, 2025
Infectious complications in CLL/SLL patients receiving Bruton's Tyrosine Kinase inhibitors - systematic review and meta-analysis of randomized controlled trialsShira Buchrits, Gal Trieman, Odil Giladi, et al.
Research and Practice in Thrombosis and Haemostasis|July 3, 2025
Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trialTzu-Fei Wang, Mari Thomas, Andrea Cervi, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 26, 2025
Prevalence and Outcome of Cerebral Microbleeds in Antiphospholipid SyndromeJonathan Naftali, Rani Barnea, Ruth Eliahou, et al.
Hematological Oncology|February 9, 2019
FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphomaIuliana Vaxman, Hanna Bernstine, Geffen Kleinstern, et al.
Experimental Hematology|October 20, 2009
Effect of imatinib on the signal transduction cascade regulating telomerase activity in K562 (BCR-ABL-positive) cells sensitive and resistant to imatinibRahav Mor-Tzuntz, Orit Uziel, Ofer Shpilberg, et al.
Haematologica|July 24, 2025
Don't lose sight: rare extramedullary involvement of myeloid/lymphoid neoplasm with ETV6:ABL1 translocation in blast phaseNeta Sternbach, Omer Y Bialer, Alon Rozental, et al.
Acta Haematologica|October 5, 2020
Leukemic Phase of Histiocytic Sarcoma of the Digestive System: A Rare Manifestation of a Rare DiseaseLiron Hofstetter, David Aranovich, Hanna Bernstine, et al.
Leukemia & Lymphoma|March 19, 2024
Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same patient: a case series and literature reviewGilad Itchaki, Osnat Jarhovsky, Jorge J Castillo, et al.
Hematological Oncology|June 8, 2020
Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignanciesIrina Amitai, Uri Rozovski, Reem El-Saleh, et al.
Pageof 28